To Study Ocular Surface Morbidities among Glaucoma Patients on Anti-Glaucoma Drops
Downloads
Published
Keywords:
.Dimensions Badge
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
© Author, Open Access. This article is licensed under a CC Attribution 4.0 License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/byncsa/4.0/.
Abstract
Title: To study ocular surface morbidities among glaucoma patients on anti-glaucoma drops.
Background: Glaucoma is a chronic, lifelong disease and it requires lifelong therapy as well. Topical anti-glaucoma drugs are often associated with symptoms and sign of toxicity.
How to Cite
Downloads
